<DOC>
	<DOC>NCT02970019</DOC>
	<brief_summary>This is a safety, tolerability and pharmacokinetic study in subjects with Parkinson's disease</brief_summary>
	<brief_title>Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>1. Willing and able to give written, and dated, informed consent (or legally acceptable representative/impartial witness when applicable) and is available for the entire study 2. Willing and able to comply with the scheduled visits, treatment plan, laboratory testing, study procedures, and restrictions (in the Investigator's opinion), and be accessible for followup 3. Male or female aged 18 to 65 years (both inclusive) 4. Diagnosed with Parkinson's disease 1. Clinical diagnosis of genetic form of Parkinson's disease, or druginduced parkinsonism 2. Diagnosis of Parkinson's disease Dementia (probable, possible) 3. Presence of severe dyskinesias 4. History of brain surgery for Parkinson's disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>